Literature DB >> 11447704

Infections associated with steroid use.

N C Klein1, C H Go, B A Cunha.   

Abstract

Patients receiving chronic steroids have an increased susceptibility to many different types of infections. The risk of infection is related to the dose of steroid and the duration of therapy. Although pyogenic bacteria are the most common pathogens, chronic steroid use increases the risk of infection with intracellular pathogens such as Listeria, many fungi, the herpes viruses, and certain parasites. Clinicians should consider both common and unusual opportunistic infections in patients receiving chronic steroids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447704     DOI: 10.1016/s0891-5520(05)70154-9

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  29 in total

Review 1.  The occurrence and prevention of foodborne disease in vulnerable people.

Authors:  Barbara M Lund; Sarah J O'Brien
Journal:  Foodborne Pathog Dis       Date:  2011-05-11       Impact factor: 3.171

Review 2.  Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors:  Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

3.  Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy.

Authors:  Ka-Eun Yoo; Rae Young Kang; Ju-Yeun Lee; Yu Jeung Lee; Sung Yun Suh; Kwi Suk Kim; Hyang Sook Kim; Se-Hoon Lee; Byung Koo Lee
Journal:  Support Care Cancer       Date:  2014-12-13       Impact factor: 3.603

Review 4.  Immunotoxicology: role in the safety assessment of drugs.

Authors:  Jacques Descotes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Infection risk in patients on multiple sclerosis therapeutics.

Authors:  Eric M Williamson; Joseph R Berger
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

6.  High-resolution CT findings of patients with pulmonary nocardiosis.

Authors:  Naoki Tsujimoto; Takeshi Saraya; Ken Kikuchi; Saori Takata; Yasuyuki Kurihara; Sayuki Hiraoka; Hiroshi Makino; Shota Yonetani; Koji Araki; Haruyuki Ishii; Hajime Takizawa; Hajime Goto
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

Review 7.  Central Nervous System Infections Associated with Immunosuppressive Therapy for Rheumatic Disease.

Authors:  Michael J Bradshaw; Tracey A Cho; Felicia C Chow
Journal:  Rheum Dis Clin North Am       Date:  2017-08-23       Impact factor: 2.670

8.  Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study.

Authors:  Idan Goren; Adi Brom; Henit Yanai; Amir Dagan; Gad Segal; Ariel Israel
Journal:  United European Gastroenterol J       Date:  2019-09-05       Impact factor: 4.623

9.  Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.

Authors:  Miguel Debono; Mike Bradburn; Matthew Bull; Barney Harrison; Richard J Ross; John Newell-Price
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

10.  Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.

Authors:  Gary R Lichtenstein; Brian G Feagan; Russell D Cohen; Bruce A Salzberg; Robert H Diamond; Samiyeh Price; Wayne Langholff; Anil Londhe; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2012-08-14       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.